Previous 10 | Next 10 |
LEXINGTON, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2020 after market close on Tuesday, August 11, 2020. ...
T2 Biosystems ( TTOO ) develops alternative diagnostic methodologies using its magnetic resonance platform referred to as T2MR. In this context, its researchers have developed a molecular COVID-19 detection test referred to as the T2SARS-COV-2. Now, there are a number of biotech companie...
3 COVID Penny Stocks To Watch After Latest News It’s earnings season and the markets are likely set for more volatility. Throw on more coronavirus cases and there could be an interesting scenario right now. The long and short of it is that penny stocks have seen quite the trickledown ...
IMV (NASDAQ: IMV ) +162% rallies on COVID-19 vaccine progress. More news on: IMV Inc., VolitionRx Limited, INmune Bio, Inc., Stocks on the move, , Read more ...
Are These The Small-Cap Health Care Stocks To Buy Or Sell This Week? Over the past decade, health care stocks have been one of the best performing sectors within the S&P 500. Even though we live in an era with impressive technologies, there are still diseases with ineffective treatment...
Gainers: MYOS RENS Technology (NASDAQ: MYOS ) +210% . More news on: MYOS RENS Technology Inc., Liminal BioSciences Inc., YRC Worldwide Inc., Stocks on the move, , Read more ...
YRC Worldwide (NASDAQ: YRCW ) +123% on receiving $700M CARES act loan from U.S. Treasury. More news on: YRC Worldwide Inc., T2 Biosystems, Inc., Akero Therapeutics, Inc., Stocks on the move, , Read more ...
Are These On Your List Of Penny Stocks To Buy Right Now? There’s a question that pops up from time to time: Should penny stocks and analyst ratings go together? A better way to ask this, in my opinion, is: should you take analyst ratings into account if you’re talking about pe...
T2 Biosystems to commercially launch the T2SARS-CoV-2 Panel in US, the new molecular diagnostic test for the detection of SARS-CoV-2. More news on: T2 Biosystems, Inc., Healthcare stocks news, Stocks on the move, Read more ...
LEXINGTON, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2 Panel. The test was developed by...
News, Short Squeeze, Breakout and More Instantly...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial and operational results for the second quarter ended Jun...
LEXINGTON, Mass., July 29, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in Malaysia and Indonesia. Under the ter...
LEXINGTON, Mass., July 22, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2024 and business updates after mar...